Loading…
Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators
The use of microfragmented adipose tissue (µFAT) for the treatment of musculoskeletal disorders, especially osteoarthritis (OA), is gaining popularity, following positive results reported in recent case series and clinical trials. Although these outcomes were postulated to rely on paracrine signals,...
Saved in:
Published in: | Journal of clinical medicine 2022-04, Vol.11 (8), p.2231 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c409t-fd9ce1325f4fad3f0ae76083c225fd7663df29391c5a8a5496632d9f990edf163 |
---|---|
cites | cdi_FETCH-LOGICAL-c409t-fd9ce1325f4fad3f0ae76083c225fd7663df29391c5a8a5496632d9f990edf163 |
container_end_page | |
container_issue | 8 |
container_start_page | 2231 |
container_title | Journal of clinical medicine |
container_volume | 11 |
creator | Ragni, Enrico Viganò, Marco Torretta, Enrica Perucca Orfei, Carlotta Colombini, Alessandra Tremolada, Carlo Gelfi, Cecilia de Girolamo, Laura |
description | The use of microfragmented adipose tissue (µFAT) for the treatment of musculoskeletal disorders, especially osteoarthritis (OA), is gaining popularity, following positive results reported in recent case series and clinical trials. Although these outcomes were postulated to rely on paracrine signals, to date, a thorough fingerprint of released molecules is largely missing. The purpose of this study was to first characterize both structure and cell content of unprocessed lipoaspirate (LA) and µFAT, and further identify and frame the array of signaling factors in the context of OA disease, by means of high throughput qRT-PCR for extracellular-vesicle (EV) embedded miRNAs and proteomics for tissue and secreted factors. Cell count showed reduction of blood cells in µFAT, confirmed by histological and flow cytometry analyses, that also showed a conserved presence of structural, endothelial and stromal components and pericytes. In the secretome, 376 and 381 EV-miRNAs in LA and µFAT, respectively, were identified. In particular, most abundant and µFAT upregulated EV-miRNAs were mainly recapitulating those already reported as ASC-EVs-specific, with crucial roles in cartilage protection and M2 macrophage polarization, while only a scarce presence of those related to blood cells emerged. Furthermore, secretome proteomic analysis revealed reduction in µFAT of acute phase factors driving OA progression. Taken together, these results suggest that processing of LA into µFAT allows for removal of blood elements and maintenance of tissue structure and stromal cell populations, and possibly the increase of OA-protective molecular features. Thus, microfragmentation represents a safe and efficient method for the application of adipose tissue properties in the frame of musculoskeletal disorders. |
doi_str_mv | 10.3390/jcm11082231 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9026471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2654278207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-fd9ce1325f4fad3f0ae76083c225fd7663df29391c5a8a5496632d9f990edf163</originalsourceid><addsrcrecordid>eNpdkc9LHDEUx0OpqKgn7xLopWC35sfMZHIpLIutgmKpeg4xeXGzzCTbJCPYc__wZtHKtjnkPV4-75v3A6FjSj5zLsnZyoyUkp4xTt-hfUaEmBHe8_db_h46ynlF6un7hlGxi_Z427QdZ80--r1Y6qRNgeR_6eJjwNHha29SdEk_jhAKWDy3fh0z4Duf8wR4nszSFzBlSvAJX0OGYJbPox7wbUlxYxcw1CvW5FCwDhb_gAF0Vaji3zf_JR-gZlqvS0z5EO04PWQ4erUH6P7r-d3iYnZ18-1yMb-amYbIMnNWGqCcta5x2nJHNIiO9NywGrKi67h1THJJTat73TayRpiVTkoC1tGOH6AvL7rr6WEEa2p1SQ9qnfyo07OK2qt_X4Jfqsf4pCRhXSNoFfj4KpDizwlyUaPPpjarA8QpK9a1DRN9HX1FP_yHruKUQm1vQzEpmJC8UqcvVB14zgncWzGUqM2C1daCK32yXf8b-3ed_A9j_qNC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2652972793</pqid></control><display><type>article</type><title>Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Ragni, Enrico ; Viganò, Marco ; Torretta, Enrica ; Perucca Orfei, Carlotta ; Colombini, Alessandra ; Tremolada, Carlo ; Gelfi, Cecilia ; de Girolamo, Laura</creator><creatorcontrib>Ragni, Enrico ; Viganò, Marco ; Torretta, Enrica ; Perucca Orfei, Carlotta ; Colombini, Alessandra ; Tremolada, Carlo ; Gelfi, Cecilia ; de Girolamo, Laura</creatorcontrib><description>The use of microfragmented adipose tissue (µFAT) for the treatment of musculoskeletal disorders, especially osteoarthritis (OA), is gaining popularity, following positive results reported in recent case series and clinical trials. Although these outcomes were postulated to rely on paracrine signals, to date, a thorough fingerprint of released molecules is largely missing. The purpose of this study was to first characterize both structure and cell content of unprocessed lipoaspirate (LA) and µFAT, and further identify and frame the array of signaling factors in the context of OA disease, by means of high throughput qRT-PCR for extracellular-vesicle (EV) embedded miRNAs and proteomics for tissue and secreted factors. Cell count showed reduction of blood cells in µFAT, confirmed by histological and flow cytometry analyses, that also showed a conserved presence of structural, endothelial and stromal components and pericytes. In the secretome, 376 and 381 EV-miRNAs in LA and µFAT, respectively, were identified. In particular, most abundant and µFAT upregulated EV-miRNAs were mainly recapitulating those already reported as ASC-EVs-specific, with crucial roles in cartilage protection and M2 macrophage polarization, while only a scarce presence of those related to blood cells emerged. Furthermore, secretome proteomic analysis revealed reduction in µFAT of acute phase factors driving OA progression. Taken together, these results suggest that processing of LA into µFAT allows for removal of blood elements and maintenance of tissue structure and stromal cell populations, and possibly the increase of OA-protective molecular features. Thus, microfragmentation represents a safe and efficient method for the application of adipose tissue properties in the frame of musculoskeletal disorders.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm11082231</identifier><identifier>PMID: 35456324</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibodies ; Blood ; Body fat ; Cartilage ; Clinical medicine ; Extracellular vesicles ; Laboratories</subject><ispartof>Journal of clinical medicine, 2022-04, Vol.11 (8), p.2231</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-fd9ce1325f4fad3f0ae76083c225fd7663df29391c5a8a5496632d9f990edf163</citedby><cites>FETCH-LOGICAL-c409t-fd9ce1325f4fad3f0ae76083c225fd7663df29391c5a8a5496632d9f990edf163</cites><orcidid>0000-0002-6463-6564 ; 0000-0003-0272-7417 ; 0000-0002-1800-3424 ; 0000-0002-9979-3092 ; 0000-0002-2996-6912 ; 0000-0003-1331-5995 ; 0000-0001-6162-8668</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2652972793/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2652972793?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35456324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ragni, Enrico</creatorcontrib><creatorcontrib>Viganò, Marco</creatorcontrib><creatorcontrib>Torretta, Enrica</creatorcontrib><creatorcontrib>Perucca Orfei, Carlotta</creatorcontrib><creatorcontrib>Colombini, Alessandra</creatorcontrib><creatorcontrib>Tremolada, Carlo</creatorcontrib><creatorcontrib>Gelfi, Cecilia</creatorcontrib><creatorcontrib>de Girolamo, Laura</creatorcontrib><title>Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>The use of microfragmented adipose tissue (µFAT) for the treatment of musculoskeletal disorders, especially osteoarthritis (OA), is gaining popularity, following positive results reported in recent case series and clinical trials. Although these outcomes were postulated to rely on paracrine signals, to date, a thorough fingerprint of released molecules is largely missing. The purpose of this study was to first characterize both structure and cell content of unprocessed lipoaspirate (LA) and µFAT, and further identify and frame the array of signaling factors in the context of OA disease, by means of high throughput qRT-PCR for extracellular-vesicle (EV) embedded miRNAs and proteomics for tissue and secreted factors. Cell count showed reduction of blood cells in µFAT, confirmed by histological and flow cytometry analyses, that also showed a conserved presence of structural, endothelial and stromal components and pericytes. In the secretome, 376 and 381 EV-miRNAs in LA and µFAT, respectively, were identified. In particular, most abundant and µFAT upregulated EV-miRNAs were mainly recapitulating those already reported as ASC-EVs-specific, with crucial roles in cartilage protection and M2 macrophage polarization, while only a scarce presence of those related to blood cells emerged. Furthermore, secretome proteomic analysis revealed reduction in µFAT of acute phase factors driving OA progression. Taken together, these results suggest that processing of LA into µFAT allows for removal of blood elements and maintenance of tissue structure and stromal cell populations, and possibly the increase of OA-protective molecular features. Thus, microfragmentation represents a safe and efficient method for the application of adipose tissue properties in the frame of musculoskeletal disorders.</description><subject>Antibodies</subject><subject>Blood</subject><subject>Body fat</subject><subject>Cartilage</subject><subject>Clinical medicine</subject><subject>Extracellular vesicles</subject><subject>Laboratories</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc9LHDEUx0OpqKgn7xLopWC35sfMZHIpLIutgmKpeg4xeXGzzCTbJCPYc__wZtHKtjnkPV4-75v3A6FjSj5zLsnZyoyUkp4xTt-hfUaEmBHe8_db_h46ynlF6un7hlGxi_Z427QdZ80--r1Y6qRNgeR_6eJjwNHha29SdEk_jhAKWDy3fh0z4Duf8wR4nszSFzBlSvAJX0OGYJbPox7wbUlxYxcw1CvW5FCwDhb_gAF0Vaji3zf_JR-gZlqvS0z5EO04PWQ4erUH6P7r-d3iYnZ18-1yMb-amYbIMnNWGqCcta5x2nJHNIiO9NywGrKi67h1THJJTat73TayRpiVTkoC1tGOH6AvL7rr6WEEa2p1SQ9qnfyo07OK2qt_X4Jfqsf4pCRhXSNoFfj4KpDizwlyUaPPpjarA8QpK9a1DRN9HX1FP_yHruKUQm1vQzEpmJC8UqcvVB14zgncWzGUqM2C1daCK32yXf8b-3ed_A9j_qNC</recordid><startdate>20220415</startdate><enddate>20220415</enddate><creator>Ragni, Enrico</creator><creator>Viganò, Marco</creator><creator>Torretta, Enrica</creator><creator>Perucca Orfei, Carlotta</creator><creator>Colombini, Alessandra</creator><creator>Tremolada, Carlo</creator><creator>Gelfi, Cecilia</creator><creator>de Girolamo, Laura</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6463-6564</orcidid><orcidid>https://orcid.org/0000-0003-0272-7417</orcidid><orcidid>https://orcid.org/0000-0002-1800-3424</orcidid><orcidid>https://orcid.org/0000-0002-9979-3092</orcidid><orcidid>https://orcid.org/0000-0002-2996-6912</orcidid><orcidid>https://orcid.org/0000-0003-1331-5995</orcidid><orcidid>https://orcid.org/0000-0001-6162-8668</orcidid></search><sort><creationdate>20220415</creationdate><title>Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators</title><author>Ragni, Enrico ; Viganò, Marco ; Torretta, Enrica ; Perucca Orfei, Carlotta ; Colombini, Alessandra ; Tremolada, Carlo ; Gelfi, Cecilia ; de Girolamo, Laura</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-fd9ce1325f4fad3f0ae76083c225fd7663df29391c5a8a5496632d9f990edf163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies</topic><topic>Blood</topic><topic>Body fat</topic><topic>Cartilage</topic><topic>Clinical medicine</topic><topic>Extracellular vesicles</topic><topic>Laboratories</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ragni, Enrico</creatorcontrib><creatorcontrib>Viganò, Marco</creatorcontrib><creatorcontrib>Torretta, Enrica</creatorcontrib><creatorcontrib>Perucca Orfei, Carlotta</creatorcontrib><creatorcontrib>Colombini, Alessandra</creatorcontrib><creatorcontrib>Tremolada, Carlo</creatorcontrib><creatorcontrib>Gelfi, Cecilia</creatorcontrib><creatorcontrib>de Girolamo, Laura</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ragni, Enrico</au><au>Viganò, Marco</au><au>Torretta, Enrica</au><au>Perucca Orfei, Carlotta</au><au>Colombini, Alessandra</au><au>Tremolada, Carlo</au><au>Gelfi, Cecilia</au><au>de Girolamo, Laura</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2022-04-15</date><risdate>2022</risdate><volume>11</volume><issue>8</issue><spage>2231</spage><pages>2231-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>The use of microfragmented adipose tissue (µFAT) for the treatment of musculoskeletal disorders, especially osteoarthritis (OA), is gaining popularity, following positive results reported in recent case series and clinical trials. Although these outcomes were postulated to rely on paracrine signals, to date, a thorough fingerprint of released molecules is largely missing. The purpose of this study was to first characterize both structure and cell content of unprocessed lipoaspirate (LA) and µFAT, and further identify and frame the array of signaling factors in the context of OA disease, by means of high throughput qRT-PCR for extracellular-vesicle (EV) embedded miRNAs and proteomics for tissue and secreted factors. Cell count showed reduction of blood cells in µFAT, confirmed by histological and flow cytometry analyses, that also showed a conserved presence of structural, endothelial and stromal components and pericytes. In the secretome, 376 and 381 EV-miRNAs in LA and µFAT, respectively, were identified. In particular, most abundant and µFAT upregulated EV-miRNAs were mainly recapitulating those already reported as ASC-EVs-specific, with crucial roles in cartilage protection and M2 macrophage polarization, while only a scarce presence of those related to blood cells emerged. Furthermore, secretome proteomic analysis revealed reduction in µFAT of acute phase factors driving OA progression. Taken together, these results suggest that processing of LA into µFAT allows for removal of blood elements and maintenance of tissue structure and stromal cell populations, and possibly the increase of OA-protective molecular features. Thus, microfragmentation represents a safe and efficient method for the application of adipose tissue properties in the frame of musculoskeletal disorders.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35456324</pmid><doi>10.3390/jcm11082231</doi><orcidid>https://orcid.org/0000-0002-6463-6564</orcidid><orcidid>https://orcid.org/0000-0003-0272-7417</orcidid><orcidid>https://orcid.org/0000-0002-1800-3424</orcidid><orcidid>https://orcid.org/0000-0002-9979-3092</orcidid><orcidid>https://orcid.org/0000-0002-2996-6912</orcidid><orcidid>https://orcid.org/0000-0003-1331-5995</orcidid><orcidid>https://orcid.org/0000-0001-6162-8668</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2022-04, Vol.11 (8), p.2231 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9026471 |
source | Open Access: PubMed Central; Publicly Available Content Database |
subjects | Antibodies Blood Body fat Cartilage Clinical medicine Extracellular vesicles Laboratories |
title | Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A53%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20Microfragmented%20Adipose%20Tissue%20Architecture,%20Mesenchymal%20Stromal%20Cell%20Content%20and%20Release%20of%20Paracrine%20Mediators&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Ragni,%20Enrico&rft.date=2022-04-15&rft.volume=11&rft.issue=8&rft.spage=2231&rft.pages=2231-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm11082231&rft_dat=%3Cproquest_pubme%3E2654278207%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-fd9ce1325f4fad3f0ae76083c225fd7663df29391c5a8a5496632d9f990edf163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2652972793&rft_id=info:pmid/35456324&rfr_iscdi=true |